ロード中...

Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries

In France, the incidence of invasive meningococcal disease (IMD) is around 1/100,000, with the following trends over the 2011–2018 period: a leading role of group B in subjects <15 years, a decrease of group C among <1 year since 2017, an increase of group W in all age groups including subject...

詳細記述

保存先:
書誌詳細
出版年:Hum Vaccin Immunother
主要な著者: Taha, Muhamed-Kheir, Gaudelus, Joël, Deghmane, Ala-Eddine, Caron, François
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644201/
https://ncbi.nlm.nih.gov/pubmed/32209010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1729030
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!